ATXI·05360L205·US·Common Stock·Healthcare - Biotechnology-Activist
ATXI (Avenue Therapeutics, Inc.) is held by 0 institutional investors as of Q1 2025. Net institutional sentiment: Bearish.
See how ATXI's score breaks down across 4 SEC sources
No institutional holders are currently tracking this security.
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer